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ABSTRACT 
 
Atypical bacteria grow very slowly in culture or they do not grow at all leading to delays in detection and diagnosis.  PCR 
multiplex was performed on template DNAs extracted from seventy three collected specimens. Thirty seven showed 
positive  indication  for  the  presence  of  bacterial  infection.  The  incidence  of  Mycoplasma  pneumoniae,  Chlamydia 
pneumonia and Legionella pneumophila as a single infecting agent was 31.5%, 27.5% and 20 % respectively. Dual 
agent infection caused by Mycoplasma + Chlamydia, Mycoplasma + Legionella and Legionella + Chlamydia was 24%, 
20% and 15% respectively. Triple agent infection caused by Legionella + Mycoplasma + Chlamydia was 17.5%. The 
etiology of the infection was M.  pneumoniae, L.  pneumophila  or C. pneumoniae as a single etiology or in combination 
of two or three organisms. 
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INTRODUCTION 
 
Acute  upper  respiratory  infections  (URI)  usually  benign, 
transitory self limited, but it could be serious disease in 
children and young infants (Phares et al., 2007). Infection 
of the lower respiratory tract, especially pneumonia, can 
be  severe  or  fatal.  Atypical  bacteria  (Mycoplasma, 
Legionella and Chlamydia) are the dominant pathogens; 
accounting  for  much  higher  percentage  of  lower  than 
upper  respiratory  tract  infections  (Welti  et  al.,  2003). 
Lower respiratory tract infections (LRTIs) continue to be 
important  cause  of  community-acquired  pneumonia  and 
therapy  is  largely  empiric  because  of  the  inability  to 
determine the causative microorganisms of most patients 
by the time treatment is initiated (Elkholy et al., 2009). 
  The classical microbiological identification techniques 
can not provide an efficient means of diagnosis because 
most of the atypical bacteria grow either slowly or  not at 
all in culture, leading to delays in detection and diagnosis 
(Sung  et  al.,  2006).  These  problems  lead  to  the 
emergence  of  other  diagnostic  methods,  such  as  L. 
pneumophila  antigen,  serologic  testing  by 
microimmunofluorescence  or compliment  fixation  assays 
and  indirect  immuno-enzyme  assay  (ELISA)  which  also 
demonstrated a lack of sensitivity and specificity (Kumar 
et al., 2007; Elkholy et al., 2009). Thereafter, nucleic acid 
amplification  based  techniques  have  been  developed  to 
diagnose  the  infections  caused  by  these  pathogens 
(Reinhard et al., 2005). Such PCR assays have lessened 
the  importance  of  culture  as  means  for  detecting  M. 
pneumoniae,  L.  pneumophila  and  C.  pneumoniae; 
showing  a sensitivity greater than culture (Matsukura et 
al., 2004).  
  Multiplex  PCR  assay  was  developed  to  detect  M.  
pneumoniae, L. pneumophila  and C. pneumonia (Kate et 
al.,  2003).  This  study  has  been  designed  to  investigate 
and  evaluate  the  incidence  of  single,  dual  and  multiple 
respiratory bacterial infections using PCR multiplex. 
 
MATERIALS AND METHODS 
 
Materials 
 
A total of 236 clinical specimens (118 males, 118 females) 
were  obtained  from  King  Saud  Chest  Hospital  (Sahari 
Hospital) in Riyadh city. The sample volume was 7,000 µL 
to  1,000  µL,  types  of  samples  were  from  pleural  fluid 
(which  have  been  taken  in  accordance  with  patients 
permission). The specimens for immediate treatment were 
stored  at  4  ° C;  others  at  –20  ° C.  Qiagen  DNA  minikit 
protocol was followed to prepare the reagents. QIAGEN 
Protease stock solution was stored at 2–8 ° C. A 5.5 mL 
protease  solvent  was  pipetted  into  the  vial  containing 
lyophilized  QIAGEN.  AL  buffer  was  stored  at  room 
temperature,  15–25  ° C,  it  was  mixed  thoroughly  by 
shaking  before  use.  An  appropriate  amount  of  ethanol 
(96–100%) was added to buffer AW1 and AW2 before use 
and stored at room temperature. 
 
Sample Processing 
 
A 200 µL of each sample was pipetted into a 1.5 mL micro 
centrifuge  tube.  A  1000  µL  of  phosphate  buffer  saline 
(PBS)  was  added  and mixed  by  vortexing  for 10 s  and 
centrifuged at 14,000 rpm for 15 s. The supernatant was 
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discarded and the pellet was resuspended in 200 µL of 
PBS and mixed by vortexing for 15 s. 
 
 
DNA extraction 
 
A 20 µL protease was pipetted into the bottom of a 1.5 mL 
microcentrifuge tube containing 200 µL of sample and 200 
µL AL buffer was added to the sample. This was followed 
by  pulse-vortexing  for  15  s.  The  sample  was  then 
incubated at 56 ° C for 10 min and centrifuged briefly. A 
200 µL ethanol (96–100%) was added, vortexed for 15 s. 
The 1.5 mL microcentrifuge tube was briefly centrifuged to 
remove drops from the inside of the lid. The mixture was 
carefully applied to the QIAamp Mini spin column, in a 2 
mL collection tube, centrifuged at 6,000 x g) for 1 min. The 
QIAamp  Mini  spin  column  was  placed  in  a  clean  2  mL 
collection  tube  and  the  tube  containing  the  filtrate  was 
discarded. A 500 µL AW1 buffer was added, centrifuged 
at( 6000 x g) for 1 min., 500 µL AW2 buffer was added, 
centrifuged  at  full  speed  (20,000  x  g)  for  3  min.  The 
QIAamp Mini spin column was placed in a clean 1.5 mL 
microcentrifuge tube and the collection tube containing the 
filtrate was discarded. The QIAamp Mini spin column was 
opened,  200  µL  of  AE  buffer  was  added,  incubated  at 
room  temperature  for  1  min,  and  then  centrifuged  at 
(6,000 x g) for 1 min. To increase the yield of the eluted 
DNA, further incubation at room temperature for 5 min and 
re-elution of the first yield was necessary. The DNA was 
concentrated  with  isopropanol  and  ammonium  acetate 
and washed with 200 µL of 75% ethanol, evaporated by 
incubating  at  65  ° C  for  5  min  and  dissolved  in  10  µL 
deionized water.  
  Primers  and  standard  control  organism  were 
purchased  from  Maxim  Biotech.  Inc.  USA.  Primers 
sequences are as follow:  
 
5’-GTTGTTCATGAAGGCCTACT-3' forward 
5'-TGCATAACCTACGGTGTGTT-3' reverse    
5'-ACCGATGCCACATCATT-3' forward 
5'-ACGACCAGTGTATTCGACAG-3' reverse  
5'-TCAATCTGGCGTGGATCTCT-3' forward 
5'-GTCACTGGTTAAACGGACTA-3' reverse 
 
Multiplex PCR profile 
 
Reaction volume 
 
A 25.0 µL, 2x PCR buffer, 5.0 µL 10x primers, 0.5 µL Taq 
polymerase  (5  U/µL),  5.0  µL  DNA,  14.5  µL  H2O,  total 
volume 50 µL.  
 
PCR Program 
 
94 ° C, 2 min for 1 cycle, 96 ° C, 1.30 min for 2 cycles, 63 
° C, 4 min for 2 cycle, (94 ° C, 1.30 min, 62 ° C, 2.30 min for 
35 cycles), 70 ° C, 10 min for 1 cycle and 4 ° C for cooling.   
Agarose  gel  electrophoresis  was  used  to  visualize 
multiplex PCR DNA product and photographed under UV.  
 
RESULTS AND DISCUSSION 
 
Thirty  seven  out  of  seventy  three  specimens  showed 
positive indication for the presence of bacterial infection. 
The  incidence  of  M.  pneumoniae,  C.  pneumonia,  L. 
pneumophila  as  a  single  infecting  agent  was  31.5%, 
27.5% and 20% respectively. Dual agent infection caused 
by  Mycoplasma  +  Chlamydia,  Mycoplasma  +  Legionella 
and  Legionella  +  Chlamydia  was  24%,  20%  and  15% 
respectively. Triple agent infection caused by Legionella + 
Mycoplasma + Chlamydia was 17.5%. The etiology of the 
infection  was  M.  pneumoniae,  L.  pneumophila  and  C. 
pneumoniae as a single etiology or in combination of two 
or  three  organisms  was  positive  for  HIV  infection.  The 
multiplex  PCR  results  are  presented  in  Figure  1  and 
detailed in Table 1. Figure 2 presents the percentage of 
patients  infected  by  single  and  multiple  agents.  M. 
pneumoniae  is  one  of  the  causative  agents  of  atypical
 
community-acquired pneumoniae (Salvatore et al., 2009). 
However, it is associated with the aggregate number of 
chronic infectious burden of atypical respiratory pathogens 
such  as  C.  pneumonia,  M.  pneumoniae  and  L. 
pneumophila.  
  Multiple  studies  have  suggested  an  association 
between  C.  pneumoniae  and  M.  pneumoniae  infection 
and  cardiovascular  disease  (Ngeh  et  al.,  2005). 
Respiratory tract infections account  more than 10% of all 
office visit to the primary care physician and restrict the 
activities of children in certain age category (5-17 years) 
due to  acute condition (Phares et al., 2007). On the other 
side community acquired pneumonia is the sixth leading 
cause  of  death  and  25%  of  patients  are  requiring 
hospitalization (Nawalutfiyya et al., 2006). Mortality among 
patients with CAP has risen due in part to an increasing 
elderly population (Liu et al., 2004). A typical pneumonia 
caused  by  C.  pneumoniae,  M.  pneumoniae  and  L. 
pneumophila  as  a  single  agent  or  mixed  infection  has 
been  detected  in  50.68%  of  all  selected  and  studied 
specimens.  It  is  an  alarming  situation  which  should  be 
taken seriously by health care system management and 
the search  for  tools  and measures to  reduce  such  high 
percentage of infection is a necessity. The question which 
should be raised concerning this observation, are Saud’s 
citizen more susceptible to pneumonia infection or it is the 
inadequate management within the hospital or even both. 
Unfortunately  we  do  not  have  the  answer  without 
investigating each part of the question.  
  However,  we  care  for  the  patients  because  the 
treatments  for  M.  pneumoniae,  C.  pneumoniae  and  L. 
pneumophila  as  a  single  infecting  agent  may  be 
achievable  but,  when  the  disease  is  a  result  of  mixed 
infection it is hard to treat in the absence of knowledge 
about the etiological agent. In mixed infection treatments 
of  a  single  agent  may  be  inhibited  and  decrease  the 
number  and  activity  of  the  organism  leading  to  the 
improvement of the patient. By contrast, due to inhibition 
of one organism the other may thrive causing the onset of 
new suffering period and so on. Death has been observed 
among  hospitalized  patients  but  our  conclusion  was 
hindered by an underling disease e.g. TB and HIV.  Mal. J. Microbiol. Vol 6(1) 2010, pp. 1-6 
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Figure  1:  Multiplex  PCR  results of  patients  showing  single,  double  and  triple infection.  Lane  M:  Marker;  Lane  (+): 
Positive control; Lane 36: Legionella; Lane 38: Mycoplasma, Legionella and Chlamydia; Lane 40: Mycoplasma and 
Legionella; Lane 43: Legionella and Chlamydia; Lane 45: Mycoplasma 
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Table 1: Interpretation of multiplex PCR results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chlamydia 
pneumonia 
Legionalla 
pneumophila  
Mycoplasma 
pneumoniae 
Prediagnosing  Nationality  Patients 
-  -  +  Resp  Saudi  1 
-  -  -  TB  Saudi  2 
-  -  +  Resp  Saudi  3 
-  -  -  Resp  Saudi  4 
+  -  +  TB  Saudi  5 
-  +  -  Resp  Saudi  6 
-  -  +  Resp  Saudi  7 
-  -  -  Resp  Saudi  8 
+  -  -  Resp  Saudi  9 
-  +  +  Reasp  Saudi  10 
-  -  -  Reasp  Saudi  11 
+  -  -  TB  Saudi  12 
-  -  +  Reasp  Saudi  13 
+  -  +  TB  Saudi  14 
-  -  -  Reasp  Saudi  15 
-  +  +  Reasp  Saudi  16 
-  -  -  TB  Saudi  17 
-  -  -  Reasp  Saudi  18 
+  -  -  Reasp  Saudi  19 
-  +  -  TB  Saudi  20 
-  -  +  TB  Saudi  21 
-  -  -  Reasp  Saudi  22 
+  -  -  Reasp  Saudi  23 
-  -  -  TB  Saudi  24 
-  -  -  Reasp  Saudi  25 
-  -  +  Reasp  Saudi  26 
+  -  -  TB  Saudi  27 
-  +  +  Reasp  Saudi  28 
-  -  -  Reasp  Saudi  29 
-  -  -  TB  Saudi  30 
-  -  -  Reasp  Saudi  31 
-  -  -  Reasp  Saudi  32 
+  -  -  Reasp  Saudi  33 
-  -  -  Reasp  Saudi  34 
-  -  -  Reasp  Saudi  35 
-  +  -  Reasp  Saudi  36 
-  -  -  TB  Saudi  37 
+  +  +  HIV+ Resp  Saudi  38 
-  -  -  Reasp  Saudi  39 
-  +  +  TB  Saudi  40 
-  -  -  Reasp  Saudi  41 
-  -  -  Reasp  Saudi  42 
+  +  -  Reasp  Saudi  43 
-  -  -  TB  Saudi  44 
-  -  +  Reasp  Saudi  45 
-  -  -  TB  Saudi  46 
-  -  -  Reasp  Saudi  47 
+  +  +  TB  Saudi  48 
-  -  -  TB  Saudi  49 
+  -  +  Reasp  Saudi  50 
-  -  -  Reasp  Saudi  51 
-  -  -  Reasp  Saudi  52 
-  -  -  Reasp  Saudi  53 
-  -  -  Reasp  Saudi  54 
-  +  +  Reasp  Saudi  55 
+  -  +  Reasp  Saudi  56 
-  -  -  Reasp  Saudi  57 
-  -  -  Reasp  Saudi  58 
-  +  +  HIV  Saudi  59 
+  +  -  TB  Saudi  60 
 
Cont. 
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However, we conclude that the use of such multiplex PCR 
systems would improve the management of adult patients 
with M. pneumoniae, C. pneumonia and L. pneumophila 
related  to  nosocomial  respiratory  bacterial  infections. 
Such molecular assay would be also valuable particularly 
with regard to disease control. Moreover, the single, dual 
and  triple  etiology  of  genetically  distinct  organisms 
indicates the possibility of repeated respiratory infections. 
 
 
 
Figure 2: Percentage of patients infected by single and  
                multiple agent 
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